PT809437E - Tiois para promover crescimento de celulas progenitoras hematopoieticas - Google Patents

Tiois para promover crescimento de celulas progenitoras hematopoieticas

Info

Publication number
PT809437E
PT809437E PT96906519T PT96906519T PT809437E PT 809437 E PT809437 E PT 809437E PT 96906519 T PT96906519 T PT 96906519T PT 96906519 T PT96906519 T PT 96906519T PT 809437 E PT809437 E PT 809437E
Authority
PT
Portugal
Prior art keywords
progenitor cells
hematopoietic progenitor
thiois
promote growth
relates
Prior art date
Application number
PT96906519T
Other languages
English (en)
Inventor
Robert L Capizzi
Alan F List
Original Assignee
Medimmune Oncology Inc
Univ Arizona
Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Oncology Inc, Univ Arizona, Arizona filed Critical Medimmune Oncology Inc
Publication of PT809437E publication Critical patent/PT809437E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT96906519T 1995-02-17 1996-02-16 Tiois para promover crescimento de celulas progenitoras hematopoieticas PT809437E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/390,713 US5846958A (en) 1995-02-17 1995-02-17 Methods of using aminothiols to promote hematopoietic progenitor cell growth

Publications (1)

Publication Number Publication Date
PT809437E true PT809437E (pt) 2005-05-31

Family

ID=23543611

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96906519T PT809437E (pt) 1995-02-17 1996-02-16 Tiois para promover crescimento de celulas progenitoras hematopoieticas

Country Status (10)

Country Link
US (2) US5846958A (pt)
EP (1) EP0809437B1 (pt)
JP (1) JP4057648B2 (pt)
AT (1) ATE285177T1 (pt)
AU (1) AU694847B2 (pt)
CA (1) CA2213322C (pt)
DE (1) DE69634074T2 (pt)
ES (1) ES2235183T3 (pt)
PT (1) PT809437E (pt)
WO (1) WO1996025045A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051563A (en) * 1997-02-12 2000-04-18 U.S. Bioscience, Inc. Methods for the administration of amifostine and related compounds
US6573253B2 (en) 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US5994409A (en) * 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6953777B2 (en) * 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
US6489312B1 (en) * 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
AU5391901A (en) * 2000-04-26 2001-11-07 Univ Oregon Health Sciences Administration of a thiol-based chemoprotectant compound
US7053072B2 (en) * 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
AU2002362088A1 (en) * 2001-12-06 2003-06-23 Catholic University Method and composition for inducing weight loss
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
BR0314356A (pt) * 2002-09-16 2005-07-19 Wyeth Corp Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
AU2003285128A1 (en) * 2002-10-31 2004-05-25 Oregon Health And Science University Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopenia
US20070148154A1 (en) * 2004-12-17 2007-06-28 Universite Rene Descartes (Paris V) Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
WO2007096901A1 (en) * 2006-02-24 2007-08-30 Natco Pharma Limited Novel dihydrate form of amifostine and process for its preparation
WO2012037283A2 (en) * 2010-09-14 2012-03-22 Mount Sinai School Of Medicine Admimistration of sns neuroprotective agents to promote hematopoietic regeration
US10780176B2 (en) 2015-11-17 2020-09-22 The Burlington Hc Research Group, Inc. Methods for improved protection and delivery of aminothiols and analogs thereof
GB201706544D0 (en) * 2017-04-25 2017-06-07 Plasticell Ltd Method
CA3071363A1 (en) 2017-07-28 2019-01-31 Nissan Chemical Corporation Additive composition for culture medium, additive compound for culture medium, and method for culture of cells or tissue using same
GB201817385D0 (en) * 2018-10-25 2018-12-12 Plasticell Ltd Therapy
TW202043199A (zh) 2019-01-30 2020-12-01 日商日產化學股份有限公司 醯肼化合物及激酶抑制劑
GB202303026D0 (en) 2023-03-01 2023-04-12 Plasticell Ltd Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892824A (en) * 1968-12-16 1975-07-01 Southern Res Inst S-{107 -({107 -aminoalkylamino)alkyl dihydrogen phosphorothioates
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
EP0394542A1 (en) * 1989-04-25 1990-10-31 American Cyanamid Company Bone marrow cell recovery with synthetic csf inducers
WO1991005571A1 (en) * 1989-10-10 1991-05-02 University Of Rochester Method for producing bone marrow growth cell factors
PT100914A (pt) * 1991-09-30 1993-10-29 Jess G Thoene Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
US5824664A (en) * 1993-03-26 1998-10-20 U.S. Bioscience, Inc. Suppression of HIV expression by organic thiophosphate

Also Published As

Publication number Publication date
CA2213322A1 (en) 1996-08-22
AU4986996A (en) 1996-09-04
CA2213322C (en) 2008-05-13
ES2235183T3 (es) 2005-07-01
MX9706255A (es) 1998-08-30
JP4057648B2 (ja) 2008-03-05
EP0809437B1 (en) 2004-12-22
AU694847B2 (en) 1998-07-30
ATE285177T1 (de) 2005-01-15
EP0809437A4 (en) 2001-05-09
US5906984A (en) 1999-05-25
US5846958A (en) 1998-12-08
EP0809437A1 (en) 1997-12-03
DE69634074D1 (de) 2005-01-27
JPH11504000A (ja) 1999-04-06
WO1996025045A1 (en) 1996-08-22
DE69634074T2 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
PT809437E (pt) Tiois para promover crescimento de celulas progenitoras hematopoieticas
ES2196082T3 (es) Analagos del factor de crecimiento de queratinocitos.
DE69830336D1 (de) Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie
ES2114786B1 (es) Tromboyetina. trombopoyetina recombinante y procedimiento de obtencion.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
GR3018304T3 (en) Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones.
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE69807672D1 (de) Von milchsäure abgeleitete butyrat-prodrugs
ATE200893T1 (de) Butyrat-medikamentvorstufen der milchsäure
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
ATE96150T1 (de) Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen.
IT1270614B (it) Proteine ad attivita&#39; antitumorale da organi di mammiferi